| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Gautam Sethi | Q50077635 |
| Kwang Seok Ahn | Q60962653 | ||
| P2093 | author name string | Alan Prem Kumar | |
| Frank Arfuso | |||
| Jae-Young Um | |||
| Anupam Bishayee | |||
| Muthu K Shanmugam | |||
| Jeong-Hyeon Ko | |||
| P2860 | cites work | Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation. | Q46034296 |
| Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis | Q46203147 | ||
| Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways | Q46367720 | ||
| Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats | Q46411332 | ||
| The effect of initiating doses of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene on the expression of PAH activating enzymes and its modulation by plant phenols | Q46435008 | ||
| Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1, COX-2, and iNOS in mouse epidermis. | Q46542008 | ||
| Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis | Q46803682 | ||
| Chemopreventive effect of trans-resveratrol--a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis | Q46843553 | ||
| Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated | Q46913650 | ||
| Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn. | Q49834882 | ||
| Influence of resveratrol on oxidative damage in genomic DNA and apoptosis induced by cisplatin | Q82407536 | ||
| Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities | Q83288932 | ||
| Modulatory influence of dietary resveratrol during different phases of 1,2-dimethylhydrazine induced mucosal lipid-peroxidation, antioxidant status and aberrant crypt foci development in rat colon carcinogenesis | Q83867996 | ||
| Correlation of total polyphenolic content with antioxidant and antibacterial activity of 24 extracts from Greek domestic Lamiaceae species | Q84914426 | ||
| Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men | Q87239863 | ||
| Bioactive natural products in cancer prevention and therapy: Progress and promise | Q88211351 | ||
| Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis | Q34613489 | ||
| The multifaceted role of curcumin in cancer prevention and treatment. | Q34667865 | ||
| Recent advances in personalized lung cancer medicine | Q34678073 | ||
| STAT3 signaling: anticancer strategies and challenges. | Q34715455 | ||
| Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells | Q34731017 | ||
| Recent advances in chemoprevention of cancer | Q34743443 | ||
| Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials | Q34776972 | ||
| The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. | Q34859478 | ||
| Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats | Q34880559 | ||
| Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. | Q34917495 | ||
| The molecular and genetic basis of colon cancer | Q35037873 | ||
| Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18 | Q35038576 | ||
| Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. | Q35081777 | ||
| Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer | Q35082241 | ||
| Molecular mechanism of the chemopreventive effect of resveratrol | Q35082245 | ||
| Resveratrol Downregulates Cyp2e1 and Attenuates Chemically Induced Hepatocarcinogenesis in SD Rats | Q35094150 | ||
| Study to evaluate molecular mechanics behind synergistic chemo-preventive effects of curcumin and resveratrol during lung carcinogenesis | Q35140169 | ||
| Resveratrol targets transforming growth factor-β2 signaling to block UV-induced tumor progression | Q35156138 | ||
| Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression | Q35185008 | ||
| Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics | Q35215147 | ||
| Natural bioactives in cancer treatment and prevention | Q35337444 | ||
| Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells | Q35585136 | ||
| Anticancer therapy targeting the apoptotic pathway | Q35603092 | ||
| The role of oxidative stress in carcinogenesis | Q35639135 | ||
| CArG-driven GADD45α activated by resveratrol inhibits lung cancer cells | Q35786657 | ||
| Enhancing the bioavailability of resveratrol by combining it with piperine | Q35807346 | ||
| DNA damage responses to oxidative stress | Q35848526 | ||
| Pathways of apoptotic and non-apoptotic death in tumour cells | Q35852309 | ||
| Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma | Q35934532 | ||
| Exploiting death receptor signaling pathways for tumor therapy | Q35976606 | ||
| Apoptosis pathway-targeted drugs--from the bench to the clinic | Q35976616 | ||
| Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential | Q36059686 | ||
| Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer | Q36082837 | ||
| Nrf2 as a novel molecular target for chemoprevention | Q36137929 | ||
| Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses | Q23921756 | ||
| Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway | Q24301518 | ||
| Influence of hypothermia on post-ischemic inflammation: role of nuclear factor kappa B (NFkappaB) | Q24338549 | ||
| Diet, nutrition, and avoidable cancer | Q24554391 | ||
| Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence | Q24618313 | ||
| Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study | Q24630364 | ||
| Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis | Q24630499 | ||
| Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine? | Q26775940 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| Resveratrol improves health and survival of mice on a high-calorie diet | Q27860950 | ||
| Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence? | Q28071699 | ||
| Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer | Q28073745 | ||
| Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition | Q28115131 | ||
| Role of transforming growth factor beta in human disease | Q28143408 | ||
| The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies | Q28242320 | ||
| Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials | Q28243127 | ||
| Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis | Q28258638 | ||
| Nuclear factor-kappaB activation: from bench to bedside | Q28262629 | ||
| Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells | Q28275069 | ||
| Cancer chemopreventive activity of resveratrol, a natural product derived from grapes | Q28300555 | ||
| A perspective on cancer cell metastasis | Q28307891 | ||
| Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages | Q28371964 | ||
| Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol | Q28373207 | ||
| Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production | Q28373255 | ||
| Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin | Q28378146 | ||
| Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70 | Q28472533 | ||
| Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells | Q28476510 | ||
| Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition | Q28477031 | ||
| Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells | Q28478548 | ||
| Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer | Q28487488 | ||
| Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner | Q28535352 | ||
| Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway | Q28541242 | ||
| The suppressive effect of resveratrol on HIF-1α and VEGF expression after warm ischemia and reperfusion in rat liver | Q28543622 | ||
| STATs in cancer inflammation and immunity: a leading role for STAT3 | Q29547203 | ||
| The biochemistry of apoptosis | Q29547741 | ||
| Caspases: killer proteases | Q29616315 | ||
| Regulation of NOXO1 activity through reversible interactions with p22 and NOXA1. | Q30156868 | ||
| Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. | Q30654525 | ||
| Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice | Q30844349 | ||
| Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor | Q30994649 | ||
| Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells | Q31394503 | ||
| Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells | Q33260568 | ||
| A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination | Q33465128 | ||
| Modulating apoptosis: current applications and prospects for future drug development | Q33547637 | ||
| Nrf2: friend or foe for chemoprevention? | Q33575690 | ||
| Resveratrol and cancer: focus on in vivo evidence | Q33578943 | ||
| Apoptosis control by death and decoy receptors | Q33597389 | ||
| Environmental factors as regulators and effectors of multistep carcinogenesis | Q33605331 | ||
| Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling | Q33698109 | ||
| Novel medicines and strategies in cancer treatment and prevention | Q33757743 | ||
| Resveratrol suppresses colitis and colon cancer associated with colitis | Q33785741 | ||
| Metabolism of chemical carcinogens | Q33846166 | ||
| Matrix metalloproteinases: biologic activity and clinical implications | Q33849967 | ||
| Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway | Q33857806 | ||
| Exacerbation of tobacco smoke mediated apoptosis by resveratrol: an unexpected consequence of its antioxidant action | Q33939226 | ||
| Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice | Q33949182 | ||
| Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice | Q33964317 | ||
| Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin | Q33982153 | ||
| Resveratrol bioavailability and toxicity in humans | Q34020588 | ||
| Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis | Q34034339 | ||
| Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors | Q34042949 | ||
| Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. | Q34095558 | ||
| Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest | Q39380056 | ||
| MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol | Q39381116 | ||
| Cisplatin and resveratrol induce apoptosis and autophagy following oxidative stress in malignant mesothelioma cells | Q39425336 | ||
| Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. | Q39469276 | ||
| Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells | Q39499880 | ||
| Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma. | Q39517822 | ||
| Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells | Q39577641 | ||
| Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3. | Q39608950 | ||
| Inducible COX-2-dependent apoptosis in human ovarian cancer cells | Q39615322 | ||
| Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling | Q39618565 | ||
| Inhibition of NF-κB signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation | Q39619523 | ||
| Resveratrol Arrests Cell Cycle and Induces Apoptosis in Human Hepatocellular Carcinoma Huh-7 Cells | Q39644247 | ||
| Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines | Q39664750 | ||
| Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma | Q39690550 | ||
| NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells | Q39721374 | ||
| Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells. | Q39743879 | ||
| Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo | Q39760176 | ||
| Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of resveratrol complexed with 2-hydroxypropyl-beta-cyclodextrin | Q39771922 | ||
| Synthesis, structural characterisation and biological evaluation of fluorinated analogues of resveratrol | Q39845203 | ||
| Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells. | Q39870498 | ||
| Antiproliferative activities of resveratrol and related compounds in human hepatocyte derived HepG2 cells are associated with biochemical cell disturbance revealed by fluorescence analyses | Q39961239 | ||
| Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells | Q39986919 | ||
| Oncogenic CARD11 mutations in human diffuse large B cell lymphoma | Q40005246 | ||
| Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells | Q40055255 | ||
| Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells | Q40080473 | ||
| Resveratrol inhibits glucose metabolism in human ovarian cancer cells | Q40083419 | ||
| Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria | Q40085440 | ||
| Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. | Q40130225 | ||
| Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines. | Q40134478 | ||
| Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9. | Q40171255 | ||
| Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas | Q40231229 | ||
| NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. | Q40252191 | ||
| Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. | Q40319010 | ||
| Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways | Q40326791 | ||
| Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. | Q40462433 | ||
| Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. | Q40462439 | ||
| trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells | Q40527959 | ||
| Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. | Q40539459 | ||
| Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats | Q40574085 | ||
| Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis | Q40594629 | ||
| Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells | Q40636195 | ||
| Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis | Q40740259 | ||
| Induction of quinone reductase activity by stilbene analogs in mouse Hepa 1c1c7 cells | Q40756723 | ||
| Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. | Q40781318 | ||
| Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines | Q40789054 | ||
| Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase | Q40821365 | ||
| Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells | Q40847302 | ||
| Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells | Q41021779 | ||
| Resveratrol: a molecule whose time has come? And gone? | Q41452058 | ||
| Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer | Q41822993 | ||
| Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer | Q41841905 | ||
| Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice | Q42204516 | ||
| Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment. | Q50512761 | ||
| Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis. | Q50540880 | ||
| Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. | Q50711998 | ||
| In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. | Q50989456 | ||
| Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells. | Q51080573 | ||
| Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. | Q51091938 | ||
| Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino-3-methylimidazo[4,5-f]quinoline. | Q51778003 | ||
| Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. | Q52573261 | ||
| Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer. | Q52682976 | ||
| Premature mitochondrial senescence and related ultrastructural changes during lung carcinogenesis modulation by curcumin and resveratrol. | Q53270682 | ||
| Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. | Q53343614 | ||
| Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. | Q53407584 | ||
| Resveratrol suppresses prostate cancer progression in transgenic mice. | Q53536458 | ||
| Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role. | Q53631902 | ||
| Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. | Q54070216 | ||
| Hypoxia-induced necrotizing enterocolitis in the immature rat: the role of lipid peroxidation and management by vitamin E | Q71483979 | ||
| The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors | Q71524901 | ||
| Screening of potential chemopreventive agents using biochemical markers of carcinogenesis | Q72789801 | ||
| Resveratrol is a potent inhibitor of the dioxygenase activity of lipoxygenase | Q73292946 | ||
| Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential | Q74081784 | ||
| Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells | Q74163308 | ||
| Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells | Q77729742 | ||
| Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice | Q77899711 | ||
| Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model | Q77911805 | ||
| The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury | Q78115656 | ||
| Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study | Q34103899 | ||
| Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. | Q34139321 | ||
| Inhibition of cancer growth by resveratrol is related to its low bioavailability | Q34139845 | ||
| Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics | Q34153260 | ||
| Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. | Q34153961 | ||
| The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. | Q34164259 | ||
| Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. | Q34168543 | ||
| NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes | Q34207369 | ||
| Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture | Q34306523 | ||
| Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis | Q34316229 | ||
| Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest | Q34329286 | ||
| Epithelial-mesenchymal transition: NF-kappaB takes center stage | Q34367143 | ||
| The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells | Q34386629 | ||
| Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis | Q34407789 | ||
| Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer | Q34418424 | ||
| Resveratrol: review on therapeutic potential and recent advances in drug delivery. | Q34420121 | ||
| Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters | Q34480835 | ||
| Natural Products as Sources of New Drugs from 1981 to 2014. | Q34512692 | ||
| Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism | Q34522777 | ||
| Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol | Q34526413 | ||
| Wine, alcohol, platelets, and the French paradox for coronary heart disease | Q34538674 | ||
| Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. | Q34548393 | ||
| Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage | Q34551489 | ||
| Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. | Q34552323 | ||
| Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? | Q34556885 | ||
| Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo | Q34563439 | ||
| Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins | Q34567861 | ||
| A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones | Q34570111 | ||
| Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth | Q34571083 | ||
| Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines | Q34571886 | ||
| Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression | Q34586249 | ||
| Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells | Q36207566 | ||
| Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo | Q36227449 | ||
| Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrol | Q36403593 | ||
| Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells | Q36625922 | ||
| Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene | Q36695705 | ||
| Reactive oxygen species: a breath of life or death? | Q36731940 | ||
| Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies | Q36759354 | ||
| Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice | Q36786996 | ||
| Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol. | Q36807739 | ||
| Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model | Q36831357 | ||
| Pathology of rodent models of intestinal cancer: progress report and recommendations | Q36865701 | ||
| Resveratrol: from basic science to the clinic | Q36921873 | ||
| Nuclear factor-kappa B: from clone to clinic | Q37017902 | ||
| NF-kappaB and epithelial to mesenchymal transition of cancer | Q37078242 | ||
| Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model | Q37177054 | ||
| Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9. | Q37188766 | ||
| Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives | Q37190153 | ||
| Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice | Q37209501 | ||
| Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes | Q37227343 | ||
| NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression | Q37286365 | ||
| Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo | Q37294641 | ||
| Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. | Q37369658 | ||
| Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. | Q37370826 | ||
| Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis | Q37383667 | ||
| Natural bioactives and phytochemicals serve in cancer treatment and prevention. | Q37433047 | ||
| Potential pharmacological control of the NF-κB pathway | Q37484609 | ||
| MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors | Q37600292 | ||
| Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention | Q37619775 | ||
| Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma | Q37632027 | ||
| Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals | Q37646827 | ||
| The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer | Q37759799 | ||
| Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. | Q37822109 | ||
| Clinical trials of resveratrol | Q37831946 | ||
| Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe | Q37835313 | ||
| Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. | Q37835758 | ||
| Multifaceted link between cancer and inflammation | Q37943405 | ||
| Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer | Q37992480 | ||
| Chemoprevention of liver cancer by plant polyphenols. | Q38004259 | ||
| Regulation of EMT by TGFβ in cancer. | Q38019712 | ||
| Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer. | Q38030337 | ||
| NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer | Q38088677 | ||
| Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery | Q38118539 | ||
| Resveratrol in the management of human cancer: how strong is the clinical evidence? | Q38121595 | ||
| The complexity of NF-κB signaling in inflammation and cancer | Q38126565 | ||
| Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. | Q38130366 | ||
| Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? | Q38262965 | ||
| NF-κB in cancer therapy. | Q38359190 | ||
| Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line | Q38364091 | ||
| Analysis of the intricate relationship between chronic inflammation and cancer. | Q38458724 | ||
| Resveratrol in the treatment of pancreatic cancer. | Q38568979 | ||
| Targeting transcription factor STAT3 for cancer prevention and therapy. | Q38610564 | ||
| Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms. | Q38698794 | ||
| Prevention and treatment of cancers by immune modulating nutrients. | Q38718929 | ||
| Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells. | Q38779367 | ||
| Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. | Q38796417 | ||
| Topical treatment with pterostilbene, a natural phytoalexin, effectively protects hairless mice against UVB radiation-induced skin damage and carcinogenesis. | Q38890614 | ||
| Resveratrol suppresses vascular endothelial growth factor secretion via inhibition of CXC-chemokine receptor 4 expression in ARPE-19 cells | Q38894373 | ||
| Polyphenols in dementia: From molecular basis to clinical trials. | Q38919226 | ||
| Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway | Q39030134 | ||
| Cancer Statistics, 2017. | Q39038674 | ||
| Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways | Q39156783 | ||
| Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage | Q39173646 | ||
| The inhibition of resveratrol to human skin squamous cell carcinoma A431 xenografts in nude mice | Q39190914 | ||
| Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation. | Q39308056 | ||
| Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells. | Q39313933 | ||
| The flavonoid resveratrol suppresses growth of human malignant pleural mesothelioma cells through direct inhibition of specificity protein 1. | Q39354770 | ||
| Grape extracts suppress the formation of preneoplastic foci and activity of fatty acid synthase in rat liver | Q42453551 | ||
| Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue | Q42707291 | ||
| Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment | Q42717496 | ||
| Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model | Q42717718 | ||
| Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. | Q42744038 | ||
| Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism. | Q42745880 | ||
| Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway | Q42748324 | ||
| SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol | Q42798510 | ||
| Extinction of rac1 and Cdc42Hs signalling defines a novel p53-dependent apoptotic pathway | Q42801438 | ||
| Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target | Q42834044 | ||
| Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. | Q43042961 | ||
| The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer. | Q43044975 | ||
| trans-Resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats | Q43045324 | ||
| Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis | Q43054538 | ||
| Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis | Q43092680 | ||
| Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells | Q43172916 | ||
| Effect of resveratrol and in combination with 5-FU on murine liver cancer | Q43245452 | ||
| Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazine-induced colon carcinogenesis | Q43264365 | ||
| Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma | Q43265295 | ||
| Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells | Q43606287 | ||
| Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. | Q43640339 | ||
| Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways. | Q43641994 | ||
| Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. | Q43654467 | ||
| Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes | Q43693027 | ||
| Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis | Q43758043 | ||
| A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma | Q43887370 | ||
| Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo | Q43897387 | ||
| Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies | Q43963634 | ||
| A comparison of the anticarcinogenic properties of four red wine polyphenols | Q43975950 | ||
| Revisiting ischemia and reperfusion injury as a possible cause of necrotizing enterocolitis: Role of nitric oxide and superoxide dismutase | Q44011055 | ||
| Cytotoxic and antimutagenic stilbenes from seeds of Paeonia lactiflora | Q44074878 | ||
| Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. | Q44084996 | ||
| Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis | Q44090241 | ||
| Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. | Q44123696 | ||
| Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats | Q44506224 | ||
| Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. | Q44528215 | ||
| Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells | Q44539335 | ||
| Prepubertal resveratrol exposure accelerates N-methyl-N-nitrosourea-induced mammary carcinoma in female Sprague-Dawley rats | Q44672494 | ||
| Antiproliferative effect of resveratrol in human prostate carcinoma cells | Q44772387 | ||
| Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin | Q44879952 | ||
| Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells | Q44895757 | ||
| The 3,4-dihydroxyl groups are important for trans-resveratrol analogs to exhibit enhanced antioxidant and apoptotic activities | Q44908805 | ||
| Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrol | Q44975292 | ||
| Resveratrol inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse skin: MAPKs and AP-1 as potential molecular targets | Q45210018 | ||
| Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells | Q45249210 | ||
| Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4'-tri-O-acetylresveratrol in rats | Q45894686 | ||
| Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. | Q45913515 | ||
| Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis. | Q45970594 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | resveratrol | Q407329 |
| stilbenoid | Q526360 | ||
| neoplasm | Q1216998 | ||
| phytogenic antineoplastic agents | Q50377200 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | The Role of Resveratrol in Cancer Therapy | |
| P478 | volume | 18 |
| Q92083058 | A Brief Overview of the Antitumoral Actions of Leelamine |
| Q61449921 | A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy |
| Q92825988 | An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases |
| Q90746600 | Antitumor Research of the Active Ingredients from Traditional Chinese Medical Plant Polygonum Cuspidatum |
| Q90382919 | Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy |
| Q90749562 | Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer |
| Q55646863 | Chemically-Induced DNA Damage, Mutagenesis, and Cancer. |
| Q90225486 | Corilagin in Cancer: A Critical Evaluation of Anticancer Activities and Molecular Mechanisms |
| Q91693060 | Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers |
| Q91971416 | Deciphering the Anti-obesity Benefits of Resveratrol: The "Gut Microbiota-Adipose Tissue" Axis |
| Q50002404 | Dental Application of Natural Products |
| Q92648565 | Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers |
| Q90613958 | Dietary Compounds for Targeting Prostate Cancer |
| Q58579018 | Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
| Q92988098 | Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways |
| Q64946875 | Focus on Formononetin: Anticancer Potential and Molecular Targets. |
| Q91813005 | Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers |
| Q92703910 | In vitro and in vivo Induction of p53-Dependent Apoptosis by Extract of Euryale ferox Salisb in A549 Human Caucasian Lung Carcinoma Cancer Cells Is Mediated Through Akt Signaling Pathway |
| Q92920728 | Insights on the Effects of Resveratrol and Some of Its Derivatives in Cancer and Autoimmunity: A Molecule with a Dual Activity |
| Q89999204 | Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy |
| Q89481554 | MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol |
| Q97524354 | Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved |
| Q90749770 | Molecular Insights into Potential Contributions of Natural Polyphenols to Lung Cancer Treatment |
| Q64273454 | Molecular Mechanisms of Action of Tocotrienols in Cancer: Recent Trends and Advancements |
| Q90397109 | Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells |
| Q97651150 | Natural Products as Modulators of Sirtuins |
| Q59128443 | Naturally occurring compounds as pancreatic cancer therapeutics |
| Q60955144 | Pharmacological Utilization of Bergamottin, Derived from Grapefruits, in Cancer Prevention and Therapy |
| Q64104369 | Pleiotropic Pharmacological Actions of Capsazepine, a Synthetic Analogue of Capsaicin, against Various Cancers and Inflammatory Diseases |
| Q64054769 | Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer |
| Q64259569 | Potential of Zerumbone as an Anti-Cancer Agent |
| Q64267771 | Preparation and Evaluation of Novel Transfersomes Combined with the Natural Antioxidant Resveratrol |
| Q64076160 | Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol |
| Q55209672 | Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers. |
| Q91705763 | Resveratrol As A Natural Regulator Of Autophagy For Prevention And Treatment Of Cancer |
| Q60960498 | Resveratrol Induces Apoptosis in Murine Prostate Cancer Cells via Hypoxia-Inducible Factor 1-alpha (HIF-1α)/Reactive Oxygen Species (ROS)/P53 Signaling |
| Q89735576 | Resveratrol Reverses Cigarette Smoke-Induced Urocystic Epithelial-Mesenchymal Transition via Suppression of STAT3 Phosphorylation in SV-HUC-1-Immortalized Human Urothelial Cells |
| Q64112604 | Resveratrol and Its Effects on the Vascular System |
| Q91906129 | Resveratrol and siRNA in combination reduces Hsp27 expression and induces caspase-3 activity in human glioblastoma cells |
| Q64111555 | Resveratrol as a Multifunctional Topical Hypopigmenting Agent |
| Q91923387 | Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9 |
| Q64279864 | Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer |
| Q89881995 | Resveratrol protects H9c2 cells against hypoxia-induced apoptosis through miR-30d-5p/SIRT1/NF-κB axis |
| Q64084615 | Role of Natural Products in Modulating Histone Deacetylases in Cancer |
| Q94551930 | Role of Resveratrol in Regulating Cutaneous Functions |
| Q89782154 | Sanggenol L Induces Apoptosis and Cell Cycle Arrest via Activation of p53 and Suppression of PI3K/Akt/mTOR Signaling in Human Prostate Cancer Cells |
| Q54209744 | Screening of melatonin, α-tocopherol, folic acid, acetyl-L-carnitine and resveratrol for anti-dengue 2 virus activity. |
| Q98891259 | Sulforaphene inhibits esophageal cancer progression via suppressing SCD and CDH3 expression, and activating the GADD45B-MAP2K3-p38-p53 feedback loop |
| Q91480154 | Targeting autophagy using natural compounds for cancer prevention and therapy |
| Q54923465 | The Anticancer Activity of Sea Buckthorn [Elaeagnus rhamnoides (L.) A. Nelson]. |
| Q90229055 | The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges |
| Q92815743 | The Plant-Derived Compound Resveratrol in Brain Cancer: A Review |
| Q97420183 | The Protection Effect of Resveratrol Against Radiation-Induced Inflammatory Bowel Disease via NLRP-3 Inflammasome Repression in Mice |
| Q91839819 | The immunomodulatory potential of natural compounds in tumor-bearing mice and humans |
Search more.